Loading company…
ID 454407277 · FY 2018–2024 · 7 years
კომპანიის ძირითად საქმიანობას წარმოადგენს სამედიცინო და ორთოპედიული საქონლით საცალო ვაჭრობა სპეციალიზებულ მაღაზიებში.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | -54 | 162 | 370 | 546 | 939 | 1,450 | 5,945 | nmf |
| Net Cash used in Investing Activities | -3 | -4 | 0 | 0 | 0 | -173 | -1 | -12.8% |
| Free Cash Flow (OCF − Capex proxy) | -56 | 157 | 370 | 546 | 939 | 1,277 | 5,943 | nmf |
| Net Cash from Financing Activities | -25 | -21 | -350 | -324 | -681 | -960 | -5,628 | nmf |
| Net Change in Cash (before FX) | -82 | 136 | 21 | 223 | 258 | 317 | 315 | nmf |
| Net Change in Cash (incl. FX) | -82 | 136 | 21 | 223 | 258 | 317 | 315 | nmf |
| Cash at Beginning of Year | 84 | 2 | 138 | 159 | 381 | 640 | 957 | +50.0% |
| Cash at End of Year | 2 | 138 | 159 | 381 | 640 | 957 | 1,272 | nmf |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2018 ₾0 · FY2019 ₾0 · FY2020 ₾239k — 3-yr total ₾239k